» Articles » PMID: 38226790

Photocontrol of the β-Hairpin Polypeptide Structure Through an Optimized Azobenzene-Based Amino Acid Analogue

Abstract

A family of neurodegenerative diseases, including Huntington's disease (HD) and spinocerebellar ataxias, are associated with an abnormal polyglutamine (polyQ) expansion in mutant proteins that become prone to form amyloid-like aggregates. Prior studies have suggested a key role for β-hairpin formation as a driver of nucleation and aggregation, but direct experimental studies have been challenging. Toward such research, we set out to enable spatiotemporal control over β-hairpin formation by the introduction of a photosensitive β-turn mimic in the polypeptide backbone, consisting of a newly designed azobenzene derivative. The reported derivative overcomes the limitations of prior approaches associated with poor photochemical properties and imperfect structural compatibility with the desired β-turn structure. A new azobenzene-based β-turn mimic was designed, synthesized, and found to display improved photochemical properties, both prior and after incorporation into the backbone of a polyQ polypeptide. The two isomers of the azobenzene-polyQ peptide showed different aggregate structures of the polyQ peptide fibrils, as demonstrated by electron microscopy and solid-state NMR (ssNMR). Notably, only peptides in which the β-turn structure was stabilized (azobenzene in the configuration) closely reproduced the spectral fingerprints of toxic, β-hairpin-containing fibrils formed by mutant huntingtin protein fragments implicated in HD. These approaches and findings will enable better deciphering of the roles of β-hairpin structures in protein aggregation processes in HD and other amyloid-related neurodegenerative diseases.

Citing Articles

Spiropyran as Building Block in Peptide Synthesis and Modulation of Photochromic Properties.

Paschold A, Starke N, Rothemund S, Binder W Org Lett. 2024; 26(49):10542-10547.

PMID: 39622009 PMC: 11650765. DOI: 10.1021/acs.orglett.4c03929.


Photocontrolled Reversible Amyloid Fibril Formation of Parathyroid Hormone-Derived Peptides.

Paschold A, Schaffler M, Miao X, Gardon L, Kruger S, Heise H Bioconjug Chem. 2024; 35(7):981-995.

PMID: 38865349 PMC: 11261605. DOI: 10.1021/acs.bioconjchem.4c00188.


Solid-state nuclear magnetic resonance in the structural study of polyglutamine aggregation.

van der Wel P Biochem Soc Trans. 2024; 52(2):719-731.

PMID: 38563485 PMC: 11088915. DOI: 10.1042/BST20230731.

References
1.
Beharry A, Woolley G . Azobenzene photoswitches for biomolecules. Chem Soc Rev. 2011; 40(8):4422-37. DOI: 10.1039/c1cs15023e. View

2.
Aguzzi A, OConnor T . Protein aggregation diseases: pathogenicity and therapeutic perspectives. Nat Rev Drug Discov. 2010; 9(3):237-48. DOI: 10.1038/nrd3050. View

3.
Chiti F, Dobson C . Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade. Annu Rev Biochem. 2017; 86:27-68. DOI: 10.1146/annurev-biochem-061516-045115. View

4.
Chen S, Ferrone F, Wetzel R . Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation. Proc Natl Acad Sci U S A. 2002; 99(18):11884-9. PMC: 129363. DOI: 10.1073/pnas.182276099. View

5.
Blanco F, Ramirez-Alvarado M, Serrano L . Formation and stability of beta-hairpin structures in polypeptides. Curr Opin Struct Biol. 1998; 8(1):107-11. DOI: 10.1016/s0959-440x(98)80017-1. View